Decorative image

Low grade NHL

Follicular lymphoma, mantle cell lymphoma and marginal zone lymphoma are all types of low grade non-Hodgkin lymphoma (NHL). Read more about the different types. 

What does low grade mean?

Doctors put NHL into 2 groups, depending on how quickly they are likely to grow and spread.

The 2 groups are low grade and high grade. The different grades of NHL are treated in slightly different ways.

Low grade NHL tends to grow very slowly. Doctors call them indolent lymphomas. 

Types of low grade NHL

Follicular lymphoma is the most common type of low grade NHL. Other types include:

  • mantle cell lymphoma
  • marginal zone lymphoma 
  • small lymphocytic lymphoma
  • lymphoplasmacytic lymphoma
  • skin lymphoma 

Over time, low grade lymphomas may change into a high grade type lymphoma. 

Follicular lymphoma

Follicular lymphoma is the most common type of low grade lymphoma. Each year around 2,500 people are diagnosed with follicular lymphoma in the UK.

Out of all people with NHL in the UK, just under 1 in every 20 people (18%) have the follicular type. It mainly affects adults over the age of 60.

Doctors might further sub divide follicular lymphoma into 3 separate grades. These are 1, 2 and 3. To get this grade, doctors looks at your lymphoma cells under a microscope. The grade is based on the number of large, follicular lymphoma cells (centroblasts) that they can see. Grade 3B follicular lymphoma is faster growing and is likely to be treated as a high grade lymphoma.

Mantle cell lymphoma

Mantle cell lymphoma is a rare type of B cell lymphoma.

Each year around 75 people are diagnosed with mantle cell lymphoma in the UK. Out of all people with NHL in the UK, less than 1 in every 100 people (1%) have mantle cell lymphoma.

Even though mantle cell lymphomas are classed as low grade, they might grow quickly. So they might be treated more like high grade lymphomas.

Marginal zone lymphoma

This is a group of slow growing B cell lymphomas.

There are 3 types of marginal zone lymphoma. It is called marginal zone lymphoma because it starts in an area of lymphoid tissue called the marginal zone. 

Mucosa associated lymphoid tissue (MALT) lymphoma 

This is the most common type of marginal zone lymphoma. You might hear it called extranodal marginal zone lymphoma.

MALT lymphoma does not start in the lymph nodes. It starts in the mucosa, which is a soft, moist tissue layer that protects and covers organs in different parts of your body. 

The most common place for it to develop is the stomach. This is called gastric MALT lymphoma.

Less commonly, it can develop in the small bowel, salivary gland, thyroid gland, tear glands or lungs. These lymphomas tend not to spread beyond the place where they started.

Nodal marginal zone lymphoma

This type of marginal zone lymphoma starts within the lymph nodes. It is sometimes called monocytoid B cell lymphoma.

Splenic marginal zone lymphoma 

This type of marginal zone lymphoma starts in the spleen but can also be found in the bloodstream. 

Small lymphocytic lymphoma

Small lymphocytic lymphoma is also called chronic lymphocytic leukaemia (CLL).

In theory, lymphoma is an illness that starts in the lymph nodes whereas leukaemia is an illness of the blood. But leukaemia and lymphoma have many similarities and often affect the body in similar ways.

Chronic lymphocytic leukaemia is the term used for this condition if many of the abnormal cells are in the blood. Doctors call it small lymphocytic lymphoma when the disease involves the lymph nodes in particular.

Lymphoplasmacytic lymphoma (including Waldenstrom's macroglobulinaemia)

In these low grade lymphomas, abnormal B cells fill up the bone marrow or enlarge the lymph nodes or spleen.

Most of these lymphomas are a type called Waldenstrom's macroglobulinaemia (or immunocytoma). People with Waldenstrom's macroglobulinaemia have a high level of a protein called immunoglobulin M (IgM) in their blood. The protein makes the blood thicker.

Skin lymphoma

Skin lymphoma is also called cutaneous T cell lymphoma. 

The most common types of skin lymphoma are:

  • mycosis fungoides 
  • sezery syndrome 

Transforming from low grade to high grade

Over time, low grade lymphomas can sometimes change into a faster growing (high grade) lymphoma. 

This change is more common in some types of NHL than others. So it does not always happen. If it does, it can happer some years after your first disgnosed with low grade NHL.

Sometimes, you can have a low grade and higher grade lymphoma at the same time. This can even happen in the same lymph node. Your doctor might assume that your low grade lymphoma is in the process of transforming to the higher grade type if this happens.

After a low grade NHL has transformed, it has to be treated as high grade. Unfortunately, a transformed NHL is generally harder to control than when it was low grade. And the treatment is more intense.

Treatment for low grade lymphomas

The type of treatment most suitable for you depends on your:

  • type of lymphoma 
  • general health 
Last reviewed: 
23 Jan 2018
  • The incidence data were compiled by the Statistical Information Team at Cancer Research UK using data from the Office for National Statistics and the regional cancer registries in Wales, Scotland and Northern Ireland using the latest data for 2017.

  • WHO classification of tumours of haematopoietic and lymphoid tissues: International Agency for Research on Cancer (4th edition)
    S Swerdlow and International Agency for Research on Cancer
    IARC Press 2008

  • Newly Diagnosed and Relapsed Mantle Cell Lymphoma: ESMO Clinical Practice Guidelines

    M Dreyling and others (2017) 

    Annals of oncology 28 (suppl 4): iv62–iv71

  • Newly Diagnosed and Relapsed Follicular Lymphoma: ESMO Clinical Practice Guidelines

    M Dreyling and others (2016) 

    Annal of oncology 27 (suppl 5): v83-v90 

  • ESMO Consensus Conference on Malignant Lymphoma: General Perspectives and Recommendations for Prognostic Tools in Mature B-cell Lymphomas and Chronic Lymphocytic Leukaemia

    M Ladetto and others 

    Annals of Oncology, 2017. 27: 2149–2160, 

  • The information on this page is based on literature searches and specialist checking. We used many references and there are too many to list here. Please contact patientinformation@cancer.org.uk with details of the particular issue you are interested in if you need additional references for this information.

Information and help

Dangoor sponsorship

About Cancer generously supported by Dangoor Education since 2010.